Vivani Medical (VANI) Change in Account Payables (2014 - 2026)
Vivani Medical (VANI) posted quarterly Change in Account Payables of $433000.0 for Q1 2026, up 147.43% year-over-year from $175000.0 in Q1 2025, and up 209.34% quarter-over-quarter from -$396000.0 in Q4 2025.
Vivani Medical (VANI) Change in Account Payables (2014 - 2026) Analysis & Trends
Vivani Medical's Change in Account Payables history runs 13 years deep, the most recent figure standing at $433000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables rose 147.43% year-over-year to $433000.0; the TTM figure through Mar 2026 stood at $36000.0 (down 90.91% YoY), while the FY2025 annual figure was -$222000.0, down 189.52% from the prior year.
- Change in Account Payables for Q1 2026 stood at $433000.0, up from -$396000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $1.3 million in Q2 2023, with the low at -$1.5 million in Q3 2022.
- The 5-year median for Change in Account Payables is $27000.0 (2024), against an average of -$122588.2.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables tumbled 5657.14% in 2022, then jumped 847.5% in 2025.
- Vivani Medical's Change in Account Payables stood at -$778000.0 in 2022, then sank by 69.67% to -$1.3 million in 2023, then surged by 98.03% to -$26000.0 in 2024, then plunged by 1423.08% to -$396000.0 in 2025, then soared by 209.34% to $433000.0 in 2026.
- Business Quant data shows VANI's Change in Account Payables at $433000.0 in Q1 2026, -$396000.0 in Q4 2025, and -$759000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | -397,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -397,000.00 |
| Jun 30, 2026 | -397,000.00 |
| Mar 31, 2026 | 433,000.00 |
| Mar 31, 2026 | 433,000.00 |
| Dec 31, 2025 | -396,000.00 |
| Dec 31, 2025 | -396,000.00 |
| Sep 30, 2025 | -759,000.00 |
| Sep 30, 2025 | -759,000.00 |
| Jun 30, 2025 | 758,000.00 |
| Jun 30, 2025 | 758,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Dec 31, 2024 | -26,000.00 |
| Dec 31, 2024 | -26,000.00 |
| Sep 30, 2024 | 167,000.00 |
| Sep 30, 2024 | 167,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Mar 31, 2024 | 27,000.00 |